Track topics on Twitter Track topics that are important to you
IRIDEX (NASDAQ:IRIX) an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, today announced the pricing of its underwritten public offering of 1,666,667 shares of its common stock at a price to the public of $6.00 per share. As quoted in the press … Continued
The post IRIDEX Announces Pricing of Public Offering of Common Stock appeared first on Investing News Network.
Original Article: IRIDEX Announces Pricing of Public Offering of Common StockNEXT ARTICLE